| |
| |
|
| Insider
Information: |
Bienaime Jean Jacques |
| Relationship: |
Director |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
539,056 |
|
|
Indirect Shares
|
247,533 |
|
|
| Direct
Value |
$43,126,444 |
|
|
|
Indirect Value
|
$21,938,850 |
|
|
| Total
Shares |
786,589 |
|
|
| Total
Value |
$65,065,294 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -34.0%
|
-5.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-10 |
474,994 |
2024-05-10 |
247,533 |
Premium* |
|
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
Chief Business Officer |
• • – |
2012-05-12 |
5 |
D |
$38.00 |
$297,160 |
D/D |
(7,820) |
149,446 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Business Officer |
• • – |
2012-10-23 |
5 |
GD |
$0.00 |
$0 |
D/D |
13,545 |
135,901 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Business Officer |
• • – |
2012-10-23 |
5 |
GA |
$0.00 |
$0 |
I/I |
13,545 |
13,545 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2014-07-31 |
5 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
226,157 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2014-10-29 |
5 |
GD |
$0.00 |
$0 |
I/I |
7,011 |
36,184 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2014-10-29 |
5 |
GA |
$0.00 |
$0 |
D/D |
7,011 |
233,168 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2014-11-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,400 |
230,768 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2015-04-17 |
5 |
GD |
$0.00 |
$0 |
D/D |
500 |
228,254 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-10-12 |
4/A |
AB |
$7.00 |
$3,500 |
D/D |
500 |
7,000 |
2.73 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2009-03-05 |
4/A |
B |
$10.04 |
$10,039 |
D/D |
1,000 |
11,917 |
2.39 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2010-12-06 |
4/A |
S |
$27.17 |
$54,348 |
D/D |
(2,000) |
93,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2010-12-06 |
4/A |
OE |
$6.46 |
$12,920 |
D/D |
2,000 |
95,567 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2011-05-25 |
4/A |
S |
$26.94 |
$26,944 |
D/D |
(1,000) |
130,093 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2013-05-12 |
4/A |
D |
$67.68 |
$591,659 |
D/D |
(8,742) |
102,165 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2017-12-14 |
4/A |
GD |
$0.00 |
$0 |
I/I |
600 |
182,201 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2018-02-26 |
4/A |
A |
$0.00 |
$0 |
D/D |
46,034 |
272,528 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2018-03-22 |
4/A |
D |
$81.36 |
$1,068,013 |
D/D |
(13,127) |
283,979 |
0 |
- |
|
| IMUX |
Immunic Inc |
Director |
– • – |
2001-04-23 |
4 |
B |
$12.00 |
$99,996 |
D/D |
8,333 |
8,333 |
2.39 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-09-01 |
4 |
AB |
$8.58 |
$38,588 |
D/D |
4,500 |
4,500 |
2.81 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-10-03 |
4 |
AB |
$8.51 |
$12,765 |
D/D |
1,500 |
6,000 |
2.81 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-10-06 |
4 |
AB |
$8.00 |
$4,000 |
D/D |
500 |
6,500 |
2.73 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-10-12 |
4 |
AB |
$7.00 |
$3,500 |
D/D |
500 |
6,500 |
2.73 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
• • – |
2005-11-01 |
4 |
AB |
$8.36 |
$12,550 |
D/D |
1,500 |
8,500 |
2.81 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
• • – |
2005-12-01 |
4 |
AB |
$9.89 |
$14,916 |
D/D |
1,500 |
10,000 |
2.81 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
• • – |
2005-12-12 |
4 |
B |
$10.21 |
$10,208 |
D/D |
1,000 |
11,000 |
2.81 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
